SCHEMBL1759238

SCHEMBL1759238

CCCC/C(C)=C\C(=O)OCC1CC1

nearest known ligand 0.35

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.34
CES1 P23141 2/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
ALDH1A1 P00352 1/20 0.32
CES2 O00748 1/20 0.32
FAAH O00519 1/20 0.32
MAPT P10636 1/20 0.32
NAAA Q02083 2/20 0.32
HCAR2 Q8TDS4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1759036 1.00 ATM (0.34) ATMCES1LMNAHPGDTSHR
SCHEMBL1759034 1.00 ATM (0.34) ATMCES1LMNAHPGDTSHR
SCHEMBL15482500 0.95 NAAA (0.37) CES1TSHRCES2FAAHNAAA
SCHEMBL15482728 0.94 NAAA (0.40) CES1TSHRCES2NAAA
SCHEMBL15482528 0.94 NAAA (0.40) CES1TSHRCES2NAAA
SCHEMBL1759150 0.90 LMNA (0.34) LMNA
SCHEMBL1759151 0.90 LMNA (0.34) LMNA
SCHEMBL1291716 0.84 LMNA (0.42) LMNANAAA
SCHEMBL1291717 0.84 LMNA (0.42) LMNANAAA
SCHEMBL15482488 0.83 NPSR1 (0.33) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8871967-B2 Esters as perfuming ingredients FIRMENICH SA (CH) 2014-10-28 US claimed
EP-2496548-B1 Esters as perfuming ingredients FIRMENICH & CIE (CH) 2013-08-28 EP claimed
EP-2496548-A1 ESTERS AS PERFUMING INGREDIENTS Firmenich S.A. (CH) 2012-09-12 EP claimed
US-20120195844-A1 ESTERS AS PERFUMING INGREDIENTS FIRMENICH SA (CH) 2012-08-02 US claimed
WO-2011055251-A1 ESTERS AS PERFUMING INGREDIENTS FIRMENICH SA (CH) 2011-05-12 WO claimed
US-8871967-B2 Esters as perfuming ingredients FIRMENICH SA (CH) 2014-10-28 US disclosed
US-8871967-B2 Esters as perfuming ingredients FIRMENICH SA (CH) 2014-10-28 US disclosed
US-8871967-B2 Esters as perfuming ingredients FIRMENICH SA (CH) 2014-10-28 US disclosed
EP-2496548-B1 Esters as perfuming ingredients FIRMENICH & CIE (CH) 2013-08-28 EP disclosed
EP-2496548-B1 Esters as perfuming ingredients FIRMENICH & CIE (CH) 2013-08-28 EP disclosed
EP-2496548-A1 ESTERS AS PERFUMING INGREDIENTS Firmenich S.A. (CH) 2012-09-12 EP disclosed
US-20120195844-A1 ESTERS AS PERFUMING INGREDIENTS FIRMENICH SA (CH) 2012-08-02 US disclosed
US-20120195844-A1 ESTERS AS PERFUMING INGREDIENTS FIRMENICH SA (CH) 2012-08-02 US disclosed
US-20120195844-A1 ESTERS AS PERFUMING INGREDIENTS FIRMENICH SA (CH) 2012-08-02 US disclosed
WO-2011055251-A1 ESTERS AS PERFUMING INGREDIENTS FIRMENICH SA (CH) 2011-05-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120195844-A1 ESTERS AS PERFUMING INGREDIENTS C5, CBR3, C1S ATM 2613/4885CES1 36/4885LMNA 1845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.